Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Albemarle Corp is a specialty chemicals business based in the US. Albemarle shares (ALB) are listed on the NYSE and all prices are listed in US Dollars. Albemarle employs 6,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $205.15 |
|---|---|
| 52-week range | $162.07 - $289.95 |
| 50-day moving average | $225.33 |
| 200-day moving average | $227.21 |
| Wall St. target price | $279.70 |
| PE ratio | 88.1772 |
| Dividend yield | $1.565 (0.76%) |
| Earnings per share (TTM) | $2.37 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $205.15 from 2022-07-01
| 1 week (2022-06-24) | -8.74% |
|---|---|
| 1 month (2022-06-02) | -18.36% |
| 3 months (2022-03-30) | -8.07% |
| 6 months (2021-12-31) | -12.24% |
| 1 year (2021-07-02) | 20.22% |
|---|---|
| 2 years (2020-07-02) | 161.14% |
| 3 years (2019-07-02) | 193.62% |
| 5 years (2017-06-30) | 94.38% |
Valuing Albemarle stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Albemarle's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Albemarle's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 88x. In other words, Albemarle shares trade at around 88x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Albemarle's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5641. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Albemarle's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Albemarle's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $939.1 million.
The EBITDA is a measure of a Albemarle's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.6 billion |
|---|---|
| Operating margin TTM | 18.77% |
| Gross profit TTM | $1 billion |
| Return on assets TTM | 3.92% |
| Return on equity TTM | 6.07% |
| Profit margin | 7.76% |
| Book value | $49.75 |
| Market capitalisation | $24.5 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Albemarle.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 41.74
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Albemarle's overall score of 41.74 (as at 12/31/2018) is pretty weak – landing it in it in the 84th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Albemarle is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 21.59/100
Albemarle's environmental score of 21.59 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.41/100
Albemarle's social score of 15.41 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.74/100
Albemarle's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Albemarle is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Albemarle scored a 1 out of 5 for controversy – the highest score possible, reflecting that Albemarle has managed to keep its nose clean.
Albemarle Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 41.74 |
|---|---|
| Total ESG percentile | 84.08 |
| Environmental score | 21.59 |
| Environmental score percentile | 7 |
| Social score | 15.41 |
| Social score percentile | 7 |
| Governance score | 13.74 |
| Governance score percentile | 7 |
| Level of controversy | 1 |
Dividend payout ratio: 29.46% of net profits
Recently Albemarle has paid out, on average, around 29.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.76% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Albemarle shareholders could enjoy a 0.76% return on their shares, in the form of dividend payments. In Albemarle's case, that would currently equate to about $1.565 per share.
While Albemarle's payout ratio might seem fairly standard, it's worth remembering that Albemarle may be investing much of the rest of its net profits in future growth.
Albemarle's most recent dividend payout was on 30 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 8 June 2022 (the "ex-dividend date").
Albemarle's shares were split on a 2:1 basis on 1 March 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Albemarle shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Albemarle shares which in turn could have impacted Albemarle's share price.
Over the last 12 months, Albemarle's shares have ranged in value from as little as $162.0742 up to $289.9527. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Albemarle's is 1.5286. This would suggest that Albemarle's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.